Janney Montgomery Scott
HRMY icon

Janney Montgomery Scott’s Harmony Biosciences HRMY Stock Holding History

Janney Montgomery Scott’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Sell
9,970
-929
-9% -$29.3K ﹤0.01% 2610
2026
Q1 		$305K Sell
10,899
-1,577
-13% -$51.7K ﹤0.01% 2370
2025
Q4 		$467K Sell
12,476
-17
-0.1% -$559 ﹤0.01% 2247
2025
Q3 		$344K Sell
12,493
-1,122
-8% -$38.7K ﹤0.01% 2407
2025
Q2 		$430K Sell
13,615
-1,299
-9% -$41.8K ﹤0.01% 2114
2025
Q1 		$495K Sell
14,914
-2,531
-15% -$90.7K ﹤0.01% 1991
2024
Q4 		$600K Buy
17,445
+1,550
+10% +$53.3K ﹤0.01% 1878
2024
Q3 		$636K Sell
15,895
-19,474
-55% -$684K ﹤0.01% 1801
2024
Q2 		$1.07M Buy
35,369
+5,395
+18% +$162K ﹤0.01% 1408
2024
Q1 		$1.01M Buy
29,974
+2,465
+9% +$79.1K ﹤0.01% 1523
2023
Q4 		$889K Buy
27,509
+6,571
+31% +$183K ﹤0.01% 1509
2023
Q3 		$686K Buy
+20,938
New +$727K ﹤0.01% 1563

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janney Montgomery Scott's HRMY Position: Q2 2026 in Review

Janney Montgomery Scott reduced its Harmony Biosciences (HRMY) stake by 8.5% in Q2 2026, selling an estimated $29.3K and leaving 9,970 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #2610.

Janney Montgomery Scott first reported a position in HRMY in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.07M in Q2 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Janney Montgomery Scott held 9,970 shares of Harmony Biosciences worth $363K as of Q2 2026.
  • Janney Montgomery Scott sold 929 Harmony Biosciences shares in Q2 2026, an estimated $29.3K.
  • Harmony Biosciences made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2610 holding.
  • Janney Montgomery Scott first reported a position in Harmony Biosciences in Q3 2023 and has held it in 12 quarters since.
  • Janney Montgomery Scott's Harmony Biosciences position peaked at $1.07M in Q2 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.